Granitero 3mg Injection is a potent antiemetic medication primarily used to prevent nausea and vomiting caused by chemotherapy, radiation therapy, and surgery. Its active ingredient, Granisetron, is a selective serotonin 5-HT3 receptor antagonist. By blocking the action of serotonin, a natural substance that can trigger nausea and vomiting, Granisetron effectively alleviates these distressing symptoms.
Granisetron works by targeting specific receptors in the brain and the gastrointestinal tract that are involved in the vomiting reflex. This targeted action makes it highly effective in managing chemotherapy-induced nausea and vomiting (CINV), both acute and delayed, as well as radiation-induced nausea and vomiting (RINV). It is also used to prevent postoperative nausea and vomiting (PONV).
The typical dosage of Granitero 3mg Injection is administered intravenously or intramuscularly. The exact dosage and frequency will be determined by a healthcare professional based on the patient’s specific condition, the type of treatment being received, and their individual response. It is crucial to follow the prescribed regimen precisely.
Common side effects may include headache, constipation, diarrhea, fatigue, and injection site reactions. Serious side effects are rare but can occur. Patients should report any unusual or severe symptoms to their doctor immediately. Granitero 3mg Injection should be stored at room temperature, protected from light and moisture. Keep out of reach of children.
